Fevertree share price: what’s the latest after reporting sales growth across all regions?
The premium producer of carbonated mixers continues to see its share price rise after reporting sales growth across all four operating regions last week ahead of its full-year results.
Fevertree Drinks has seen its share price climb more than 25% since reporting continued sales growth across all four operating regions in an unscheduled trading update last week ahead of its full-year results.
The supplier of premium carbonated mixers said that it expects to record double-digit revenue growth in 2019, with its US division performing ahead of expectations in the second half.
‘We continue to see growth across all four regions,’ Fevertree CEO Tim Warrillow said. ‘Indeed, sales accelerated in our key growth markets of the US and Europe.’
‘Fever-Tree's progress in the US is particularly encouraging and the signing of a US bottling partner is a further step in building our operations in this exciting market,’ he added.
Fevertree expects 13% revenue growth in 2019
Following a strong performance across all four regions, the company now expects to generate total revenue of between £266 million to £268 million, representing 12% - 13% growth, with margin forecasts unchanged.
Analysts had been forecasting sales of between £272 million to £275 million in 2019.
Fevertree said sales in the US have accelerated in the second half of 2019, with distribution expansion across the company's key off-trade accounts (sales via supermarkets and shops) and further distribution gains in on-trade (sales via restaurants and bars).
Looking to trade Fevertree? Open a live or demo account with IG.
HSBC optimistic about the Fevertree share price
HSBC remains the most optimistic about the Fevertree share price, with analysts at the bank reiterating their ‘buy’ rating for the stock and issuing a target price of £33 a share.
Based on the stock closing at £21.85 on Monday, HSBC believes the stock has a potential upside of 51%.
However, other analysts from RBC, Jefferies, Deutsche Bank and JP Morgan are less enthusiastic about the stock, with the four banks issuing target prices between £22 to £24, representing a potential upside of between 0.7% and 9.8%.
You can go long or short Fevertree with IG using derivatives like CFDs.
This information has been prepared by IG, a trading name of IG Australia Pty Ltd. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get commission from just 0.08% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets
- Forex
- Shares
- Indices
